Roche and Takeda try on Emulate’s 'organ chip' tech for R&D
Two pharma giants — Roche and Takeda — are buying into a drug testing technology that wants to be the next generation’s “lab rat,” inking partnerships with the tech’s maker to introduce the systems to their R&D labs.
The tech, made by Wyss Institute spinoff Emulate, includes small chips designed to hold living cells in chambers. These chips are engineered to recreate the environment cells might experience in the human body, introducing mechanical forces that mimic breathing, for example.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.